PRESS RELEASES

Found 271 Results
Page 1 of 28

Onxeo publishes Letter to Shareholders and provides update on its developments


Paris (France), February 2, 2021 – 9 pm CET – Onxeo S.A. (Euronext Growth: ALONX; Nasdaq First North: ONXEO), a […]

02/02/2021


Onxeo Obtains Non-Dilutive Financing of 5 Million Euros in the Form of State Guaranteed Loans


This financing extends the Company’s cash horizon to the 3rd quarter of 2022   Paris (France), January 28, 2021 – […]

01/28/2021


Onxeo to Attend Key Investor and Scientific Conferences


Paris (France), January 11, 2021 – 7:00 am CET – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the […]

01/11/2021


2020 – Full-year report on the liquidity contract


2020 Full-year report on the liquidity contract

01/08/2021


Onxeo Announces its Financial Agenda for 2021


Paris (France), January 7, 2021 – 6 pm CET – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the […]

01/07/2021



Onxeo Announces the Transfer of the Listing of its Shares to Euronext Growth Paris on December 15, 2020


Paris (France), December 10, 2020 – 6 pm CET – Onxeo S.A. (ISIN: FR0010095596), (“Onxeo” or “the Company”), a clinical-stage […]

12/10/2020




Page 1 of 28